An ancient conflict between hosts and pathogens has driven the innate and adaptive arms of
immunity. Knowledge about this interplay can not only help us identify biological …

Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …

Importance Treatment options for COVID-19 are warranted irrespective of the presence of
risk factors for severe disease. Objective To assess the efficacy and safety of ensitrelvir in …

In utero exposure to COVID-19 infection may lead to large intergenerational health effects.
The impact of infection exposure has likely evolved since the onset of the pandemic as new …

Background: Patients hospitalized with COVID-19 have an increased incidence of
thromboembolism. The role of extended thromboprophylaxis after hospital discharge is …

Accumulating evidence shows that SARS‐CoV‐2 can potentially trigger autoimmune
processes, which can be responsible for the long‐term consequences of COVID‐19 …

Summary G3BP1/2 are paralogous proteins that promote stress granule formation in
response to cellular stresses, including viral infection. The nucleocapsid (N) protein of …

This study aimed to compare the clinical picture of COVID-19 in the initial and later period of
Omicron dominance and to identify populations still at risk. A retrospective comparison of the …

SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) are major infectious causes of death,
with meta-analyses and population-based studies finding increased mortality in co-infected …

Purpose SARS-CoV-2 infections cause COVID-19 and have a wide spectrum of morbidity.
Severe disease courses among children are rare. To date, data on the variability of morbidity …